At this time, posts about Hanmi Pharm are rapidly increasing on portals and securities communities. Today, foreigners have sold a net 6,000 shares of Hanmi Pharm, while institutions have bought a net 14,000 shares, according to provisional data. Hanmi Pharm is known as a pharmaceutical company specializing in the production of prescription drugs.


As of 12:30 PM on the 30th, Hanmi Pharm's stock price is 362,500 KRW, up 4.02% from the previous day, with a trading volume of 191,549 shares, which is 189.62% of the 5-day average trading volume.


In addition to Hanmi Pharm, posts by investors are also surging for Jongkundang (185750), KMH (122450), and Kinemaster (139670).



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing